As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in coming days, analysts and especially investors will keep their eyes on whether the ...

Under the terms of the deal, Gilead will put down $120 million in an upfront payment and will promise up to $1.52 billion in ...

Explore the impact of lysosomal lipid recycling in a rare multi-organ disorder linked to the SPNS1 gene mutations.

Scientists armed bacteria with cancer-killing viruses that infiltrate tumors, evade immunity, and attack from within.

Researchers create an artificial genetic system mimicking reverse translation, converting music into DNA to explore ...

Stroke risk evolves across the lifespan, with distinct sex-specific differences that remain underappreciated in both research ...

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

UD researchers study how protein coatings influence nanoparticles' ability to avoid immune clearance and reach their ...

As a revolutionary 3D cell culture system, organoids bridge the gap between traditional 2D models and animal studies. This review synthesizes the ...

Japan is widely recognized for its highly advanced pharmaceutical industry, supported by a strong scientific foundation, a rigorous regulatory framework, and a deep commitment to safety and quality.

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” third-quarter ...